Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dusit Lumlertkul"'
Autor:
Dusit Lumlertkul, Niwat Maneekarn, Derek Bannachak, Mark H. Kuniholm, Satawat Thongsawat, Chansom Pantip, Amornrat Thungsuputi, Kenrad E. Nelson
Publikováno v:
Journal of Medical Virology. 80:808-815
Control of hepatitis C virus (HCV) in hemodialysis populations is a major public health priority, but the preferred methods to prevent and rapidly detect HCV outbreaks in these populations remains subject to debate. We enrolled 231 hemodialysis patie
Autor:
Kearkiat, Praditpornsilpa, Sookruetai, Lekhyananda, Nalinee, Premasathian, Pornchai, Kingwatanakul, Adisorn, Lumpaopong, Pongsathorn, Gojaseni, Amporn, Sakulsaengprapha, Wisit, Prasithsirikul, Bunyong, Phakdeekitcharoen, Kumthorn, Lelamali, Tavichai, Teepprasan, Chatsuda, Aumanaphong, Benjaporn, Leerawat, Jintana, Pongpiyadej, Soysaang, Srangsomvong, Talerngsak, Kanjanabuch, Somchai, Eiam-Ong, Kriengsak, Vareesaengthip, Dusit, Lumlertkul
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 94
The national health insurance fund in Thailand initiated by the national health security act in November, 2002. In October 2007, the national health insurance fund launched the first renal replacement therapy (RRT) reimbursement plan by the "Peritone
Autor:
Somchai Eiam-Ong, Tanyarat Teerapornlertratt, Yingyos Avihingsanon, Kearkiat Praditpornsilpa, Dusit Lumlertkul, Paweena Susantitaphong, Talerngsak Kanjanabuch, Kriang Tungsanga, Natavudh Townamchai, Saengsuree Jootar, Pawinee Kupatawintu, Tanin Intragumtornchai, Khajohn Tiranathanagul, Pisut Katavetin
Publikováno v:
Kidney international. 80(1)
Recombinant human erythropoietin (r-HuEpo) has been used for the treatment of renal anemia. With the loss of its patent protection, there has been an upsurge of more affordable biosimilar agents, increasing patient access to treatment for these condi